Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Subjects With Knee Osteoarthritis

Trial Profile

A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Subjects With Knee Osteoarthritis

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jan 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Calcitonin (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Registrational; Therapeutic Use
  • Acronyms OA 2 Study
  • Sponsors Nordic Bioscience
  • Most Recent Events

    • 15 Nov 2023 Results of post-hoc analysis of two studies (NCT00486434 and NCT00704847) assessing the effects of commonly used medications on changes in structural outcomes and WOMAC pain over a two-year period, presented at the ACR Convergence 2023.
    • 03 Jun 2023 Results of post-hoc analysis assessing the impact of common demographic and pain characteristics on the SD of mean pain change from baseline in a large interventional OA trial database, presented at the 24th Annual Congress of the European League Against Rheumatism.
    • 04 Jun 2022 Results of post-hoc analysis of two studies (NCT00486434 and NCT00704847) assessing antihistamine use during a two-year trial period and differences in structural progression, presented at the 23rd Annual Congress of the European League Against Rheumatism.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top